Showing results (231-240 of 253) with videos related to

Sort By:
Pageof 26
Pharmacological Research|March 17, 2024
Efficacy of erythropoietin as a neuroprotective agent in CKD-associated cognitive dysfunction: A literature systematic reviewMichelangela Barbieri, Paolo Chiodini, Piergiacomo Di Gennaro, et al.
Pharmaceuticals (Basel, Switzerland)|December 18, 2020
Preliminary Results of the FASM Study, an On-Going Italian Active Pharmacovigilance ProjectGiorgia Teresa Maniscalco, Vincenzo Brescia Morra, Ciro Florio, et al.
Frontiers in Public Health|April 28, 2025
Oropharyngeal adverse drug reactions: knowledge, attitudes, and practice (KAP) among Italian healthcare professionals and studentsGaetano La Mantia, Giulia Marcon, Martina Coppini, et al.
Pharmacological Research|June 13, 2022
Angiotensin receptor/Neprilysin inhibitor effects in CRTd non-responders: From epigenetic to clinical besideCelestino Sardu, Massimo Massetti, Lucia Scisciola, et al.
Drug Safety|April 18, 2013
Idiopathic acute liver injury in paediatric outpatients: incidence and signal detection in two European countriesCarmen Ferrajolo, Katia M C Verhamme, Gianluca Trifirò, et al.
Clinical Drug Investigation|July 20, 2024
The Early Access and the Potential Cost Savings by the Compassionate Use of Onco-haematological Drugs: Results from the Italian Study Compass-OIrene Dell'Anno, Leonardo Dondi, Immacolata Esposito, et al.
Pharmacological Research|May 4, 2020
Amelioration of diastolic dysfunction by dapagliflozin in a non-diabetic model involves coronary endotheliumDonato Cappetta, Antonella De Angelis, Loreta Pia Ciuffreda, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|March 13, 2025
Facts and figures of the compassionate use of onco-hematological drugs from 2016 to 2021: Results from the multicentric observational study Compass-OAnnamaria Mascolo, Irene Dell'Anno, Leonardo Dondi, et al.
Pageof 26